- Home
- CCCC
CCCC
C4 Therapeutics Inc.
as 07-26-2024 4:00pm EST
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 423.8M | IPO Year: | 2020 |
| Target Price: | $8.71 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.06 - $11.88 | Next Earning Date: | 08-06-2024 |
| Revenue: | $20,036,000 | Revenue Growth: | -26.34% |
| Revenue Growth (this year): | 26.24% | Revenue Growth (next year): | -34.34% |
Latest C4 Therapeutics Inc. News
CCCC Breaking Stock News: Dive into CCCC Ticker-Specific Updates for Smart Investing
Zacks
10 days ago
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
GlobeNewswire
10 days ago
C4 Therapeutics to Present Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024
Zacks
17 days ago
C4 Therapeutics (CCCC) Upgraded to Buy: Here's Why
GlobeNewswire
19 days ago
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
Insider Monkey
a month ago
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?
Simply Wall St.
a month ago
It Looks Like C4 Therapeutics, Inc.'s (NASDAQ:CCCC) CEO May Expect Their Salary To Be Put Under The Microscope
MT Newswires
2 months ago
C4 Therapeutics Appoints Ron Cooper Board Chairman
GlobeNewswire
2 months ago
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
Compare CCCC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CCCC C4 Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.